Pseudogenes are genes with high sequence homology to functional genes that have been rendered obsolete by mutations, preventing their expression. Several genes, such as α -and β -globin, have been shown to have duplicated sequences representing nonfunctional genes or pseudogenes. The presence of pseudogenes is common; not every DNA duplication produces a functional gene.
Cyclophilin (CyP), an 18-kDa protein originally isolated as the main cyclosporin A-binding protein (1) , is a major cellular component, comprising 0.1% to 0.4% of total cellular protein (7) . CyP expression is not restricted to a specific cell type but is found in all cells of wide phylogenetic distribution (5, 7, 9) and might therefore be useful as a housekeeping gene for comparative quantitation of mRNA by reverse transcription polymerase chain reaction (RT-PCR). However, Southern blot analysis of mammalian genomic DNA has revealed multiple CyP-homologous sequences representing related genes or pseudogenes (2, 3) . Notwithstanding the existence of these pseudogenes, we investigated its use for this purpose with RNA extracted from human peripheral blood mononuclear cells (PBMCs). The cyclophilin primer sequences were obtained from the nucleotide sequence of Haendler and Hoffer (4) and designed to span an intron amplifying a 597-bp fragment. The primer pair sequences used in the amplification process were 3317 (5 ′ -ATGGTCAACCCCACCGTGTTCTT -CGAC-3 ′ ) and 3318 (5 ′ -AATCGAGT -TGTCCACAGTCAGCAATGG-3 ′ ).
Initial results showed the presence of an amplified band of the expected size in the controls where the RNA had not been reverse-transcribed. Upon further investigation of the primer sequence and positioning, we discovered that although the primers were designed across an intron, the DNA sequence and RNA sequence showed high homology, and the above primers would therefore be likely to amplify any DNA contaminating the RNA preparations. We describe a simple method for the preparation of RNA suitable for RT-PCR when RNA-specific primers cannot be designed and that can be used even when pseudogenes are a confounding problem.
To minimize the amount of cellular DNA contamination within the RNA preparations, two different methods of RNA extraction were compared. First, total RNA was extracted from 1 ×10 6 PBMCs isolated from buffy packs using Ficoll-Paque ® density gradients (Pharmacia Biotech, Uppsala, Sweden) using Total RNA Isolation Reagent (Advanced Biotechnologies, London, England, UK) according to the manufacturer's protocol. First-strand cDNA synthesis was then performed in a 20-µ L reaction mixture containing 25 ng Vol. 24, No. 4 (1998) Benchmark s oligo(dT) primer (Promega, Madison, WI, USA), 5 mM MgCl 2 , 1 ×PCR buffer (Promega), 1 mM dNTPs and 1 U/ µ L RNasin ® (Promega). Samples were prepared in duplicate and incubated both with and without 50 U of Moloney murine leukemia virus (MuLV) Reverse Transcriptase (Perkin-Elmer, Norwalk, CT, USA) for 30 min at 42°C, 99°C for 5 min and 0°C for 5 min.
The second method used was direct poly(A) + mRNA extraction using magnetic Dynabeads ® Oligo(dT) 25 (Dynal, Oslo, Norway) at a concentration of 25 µ L of beads/1 × 10 6 cells. PBMCs were prepared as above, lysed according to the manufacturer's instructions and the samples converted to cDNA in a 20-µ L reaction mixture as above, but using the Dynabeads Oligo(dT) 25 as a primer.
The cDNA prepared from the total RNA was amplified in a 100-µ L PCR mixture containing 20 µ L of cDNA, a final concentration of 2mM MgCl 2 , 1 × PCR buffer, 0.2 mM dNTPs, 2.5 U Taq DNA polymerase (Promega) and 0.4 µ M of each CyP primer. The cDNA prepared from the mRNA was amplified in 50-µ L PCR mixtures, using the bead/cDNA complex in the above conditions. The PCRs were carried out in a GeneAmp ® PCR System 9600 Thermal Cycler (Perkin-Elmer) for 35 cycles (94°C for 45 s, 60°C for 45 s and 72°C for 2 min). PCR samples (10 µ L) were analyzed by electrophoresis in 2% agarose gels and stained with ethidium bromide.
Analysis of the control PCR-amplified samples (to which no reverse transcriptase had been added in the firststrand cDNA synthesis step) of both the mRNA and total RNA preparations revealed an approximately 600-bp product ( Figure 1, lanes 3, 5 and 7 ) that was not detected in negative controls containing no DNA (Figure 1, lane 11) . Repeat extractions of both total RNA and mRNA produced the same results.
To confirm that the primers were amplifying CyP genes from cellular DNA as well as cDNA from RNA, 1 ×10 6 PBMCs were lysed as described by Lee et al. (8) and the cell lysate amplified using the CyP primers. CyP-specific bands of approximately 600 bp were again found ( Figure 1, lane 10) . The broadness of several of the bands suggests the possibility of multiple amplified PCR products representing both mRNA and DNA of slightly different sizes.
On reexamination of the complete nucleotide sequence of the human CyP gene (6) to ensure that the primers were located on either side of an intron, the primers were found to be separated by 4660 nucleotides and should thus only amplify a 597-bp product from mRNA. However, a check of sequence homology using the program CLUSTAL (PC/Gene ® ; IntelliGenetics, Mountain View, CA, USA) revealed that there were 6 human CyP-related processed pseudogenes (European Molecular Biology Laboratory [EMBL] database) with homology to the mRNA sequence ranging from 85% to 97%. Amplification of this pseudogene DNA with the CyP primers would yield products similar in size to that from mRNA. Because of the sequence homology, it was impossible to design primers specific only for RNA amplification.
To determine if there was any haplotype variation between donors, PBMCs were isolated from 10 buffy packs (Red Cross Blood Bank, Melbourne, Australia). DNA was extracted from the PBMCs and amplified using the CyPspecific primers. The DNA was serially diluted and the PCR products run on agarose gels. The results (not shown) demonstrated that there were no apparent differences in the number of pseudogenes nor polymorphism in the size of the amplified product among these different donors.
In an attempt to improve the RNA extraction methods to remove any contaminating DNA so that the CyP primers could then be used to standardize mRNA levels between samples, both extraction techniques were again performed. This time the samples were incubated for 30 min at room temperature in either the presence or absence of 1 U/ µ L RNase-free DNase I (Boehringer Mannheim, Castle Hill, NSW, Australia) in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 and 0.1 mM dithiothreitol (DTT) before cDNA synthesis. The DNase was then removed using phenol/chloroform extraction and ethanol precipitation. The result of this DNase pretreatment of both total RNA and mRNA is shown in Figure 1 . No band was found in the absence of reverse transcriptase for mRNA extracted using oligo(dT) beads and treated with DNase (lane 9). In contrast, DNase pretreatment failed to remove all contaminating DNA from the total RNA preparation (lane 5).
Even with the confounding problem of multiple pseudogenes, CyP primers can still be used to quantify mRNA 586BioTechniques
Vol. 24, No. 4 (1998) after ensuring that RNA preparations are free from contaminating DNA. This can be achieved using mRNA prepared with Dynabeads Oligo(dT) 25 , then pretreated with DNase. Furthermore, our findings highlight the need to check for DNA contamination when amplifying cellular RNA, even when poly(A) + mRNA has been prepared and primers have been designed to span an intron, by including a control reaction mixture with no reverse transcriptase.
